|
- 2018
Phase 1 Parkinson’s Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well ToleratedDOI: 10.1007/s40120-018-0114-z Keywords: Dopamine D1 receptor, Dopamine D5 receptor, Dopamine receptor agonists, Parkinson’s disease Abstract: The online version of this article (10.1007/s40120-018-0114-z) contains supplementary material, which is available to authorized users
|